Citadel Advisors’s NuCana NCNA Stock Holding History
Bought
Maintained
Sold
Other funds holding NCNA
SG
HF
GJIA
CIAM
SS
Citadel Advisors's NCNA Position: Q2 2026 in Review
Citadel Advisors increased its NuCana (NCNA) stake by 96% in Q2 2026, buying an estimated $26.5K and bringing the position to 27,099 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #13210.
Citadel Advisors first reported a position in NCNA in Q3 2017 and has held it in 16 quarters since. The position peaked at $1.22M in Q3 2017. 10 funds tracked by Wall St. Rank hold NCNA as of Q2 2026.
- Citadel Advisors held 27,099 shares of NuCana worth $41.2K as of Q2 2026.
- Citadel Advisors bought 13,244 NuCana shares in Q2 2026, an estimated $26.5K.
- NuCana made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13210 holding.
- Citadel Advisors first reported a position in NuCana in Q3 2017 and has held it in 16 quarters since.
- Citadel Advisors's NuCana position peaked at $1.22M in Q3 2017.
- 10 funds tracked by Wall St. Rank held NuCana as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.